https://www.centerforbiosimilars.com/news/fda-approves-celltrions-rituximab-biosimilar-truxima
Thought this may be interesting for some of us currently on Rituximab.
- Mark
"Notably, while the reference rituximab also carries indications for inflammatory diseases including rheumatoid arthritis, Celltrion sought approval only for indications in oncology."
-Does this mean it can't be prescribed for autoimmunes as well?
Yes, no, maybe?
In the long run it may be a viable treatment if the biosimilar is essentially as efficous as Rituximab.
Short term probably for NHL only. Something I intend to ask about though.